investordatabase.org

Goddess Gaia Ventures

goddessgaiaventures.com Direct investor

GG Ventures is a venture capital firm focused on women's health and female performance. It invests in early-stage companies developing technologies for female-specific health, performance, and longevity.

Goddess Gaia Ventures is a venture capital firm headquartered in London, United Kingdom, founded in 2021. It invests directly in companies, from seed to Series A, in women's health, female performance, longevity and sports. 15 portfolio companies, as it reports.

“We invest with early conviction from Seed to Series A in exceptional companies capable of defining their categories.”

— Goddess Gaia Ventures, own website
Layer
Direct investor
Type
Venture capital
Stage
Seed – Series A
Headquarters
London, United Kingdom
Invests in
Europe
Sectors
women's health, female performance, longevity, sports, strength & wellness, chronic disease, female cancers, mental health & healthtech, next-gen reproductivity
Founded
2021
Portfolio
15 companies

Team, as Goddess Gaia Ventures publishes it

  • Priya Oberoi FOUNDING GENERAL PARTNER
  • AYA SUZUKI, CFA HEAD OF OPERATIONS, PARTNER
  • LAUREN GEORG VENTURE PARTNER
  • MARISSA K. FAYER INVESTMENT COMMITTEE MEMBER
  • Camilla Harder Hartvig Board Member
  • Jane van Dis Board Member
  • Baroness Sandy Verma Member of the House of Lords since 2006. Former Minister and Champion for Equality and Gender issues
  • Colin Bennett Honorary Professorial Fellow, School of Life Sciences at University of Warwick. Formerly Nuffield Department of Medicine at University of Oxford.
  • Keri Hildick Reimbursement Insurance Expert. Chief Strategy Officer at Perspectum Diagnostics Ltd. Former Healthcare Analyst at Sociable Pharma. Former Associate Scientist at GlaxoSmithKlin.
  • Evelyn Bourke Insurance Expert. Former CEO at BUPA Group; Non-Executive Director at AJ Bell and Admiral Group Plc.
  • Professor Dame Clare Gerada DBE Board Member. Former Chair and President of the Royal College of General Practitioners (RCGP); Co-Chair of NHS Assembly.
  • Professor Chas Bountra Technology Advisor. Pro-Vice Chancellor for Innovation at University of Oxford. Professor of Translational Medicine and Head of Impact & Innovation at Nuffield Department of Clinical Medicine, University of Oxford.

Names and roles exactly as listed on goddessgaiaventures.com. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page Goddess Gaia Ventures publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 8539 · added 2026-09-29 · link last verified 2026-09-29 · confidence high

Similar investors

  • Hiro Capital LLP
    Venture capital · Series A – Growth · London, United Kingdom
  • 2150
    Venture capital · London, United Kingdom
  • 4BIO Partners LLP
    Venture capital · Seed – Series A · London, United Kingdom
  • Abingworth
    Venture capital · Seed – Series C+ · London, United Kingdom
  • Active Partners
    Venture capital · London, United Kingdom
  • Ada Ventures
    Venture capital · Pre-seed – Seed · London, United Kingdom

Listed under